Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,690 | 105 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $626.48 | 16 | $0 (2024) |
| Lilly USA, LLC | $265.69 | 9 | $0 (2024) |
| Novo Nordisk Inc | $256.92 | 9 | $0 (2024) |
| ABBVIE INC. | $204.97 | 6 | $0 (2024) |
| PFIZER INC. | $200.39 | 10 | $0 (2024) |
| Amgen Inc. | $188.64 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $135.66 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $125.79 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $76.62 | 4 | $0 (2024) |
| Averitas Pharma Inc. | $70.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,359 | 55 | AstraZeneca Pharmaceuticals LP ($287.62) |
| 2023 | $1,136 | 39 | AstraZeneca Pharmaceuticals LP ($322.38) |
| 2022 | $107.09 | 6 | Dexcom, Inc. ($23.95) |
| 2020 | $48.47 | 3 | Alexion Pharmaceuticals, Inc. ($18.78) |
| 2019 | $11.81 | 1 | Novartis Pharmaceuticals Corporation ($11.81) |
| 2017 | $27.70 | 1 | PFIZER INC. ($27.70) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $35.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: VACCINE | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 195 | 230 | $33,915 | $19,347 |
| 2022 | 8 | 229 | 405 | $47,467 | $26,546 |
| 2021 | 7 | 360 | 670 | $102,414 | $57,957 |
| 2020 | 7 | 281 | 408 | $55,273 | $30,642 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 106 | $14,840 | $7,839 | 52.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 43 | 47 | $8,249 | $4,684 | 56.8% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 29 | 31 | $6,502 | $4,627 | 71.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 46 | $4,324 | $2,198 | 50.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 82 | 221 | $20,332 | $12,196 | 60.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 52 | $6,916 | $4,095 | 59.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 37 | 38 | $7,296 | $3,049 | 41.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $3,717 | $2,146 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 30 | $2,862 | $1,586 | 55.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 11 | 13 | $2,282 | $1,462 | 64.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 16 | $2,242 | $1,229 | 54.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $1,820 | $782.92 | 43.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 166 | 464 | $61,712 | $37,680 | 61.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 78 | 81 | $15,552 | $6,764 | 43.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 41 | $10,660 | $6,452 | 60.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 26 | $3,666 | $2,065 | 56.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 31 | 31 | $4,030 | $1,761 | 43.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 13 | 13 | $4,316 | $1,727 | 40.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $2,478 | $1,507 | 60.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 69 | 143 | $19,019 | $11,818 | 62.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 69 | 69 | $13,248 | $5,436 | 41.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 52 | 89 | $8,188 | $4,898 | 59.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 29 | $7,540 | $4,640 | 61.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 18 | 18 | $2,358 | $1,435 | 60.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 24 | 24 | $3,120 | $1,374 | 44.0% |
About Dr. Robert Han, MD
Dr. Robert Han, MD is a Internal Medicine healthcare provider based in Owosso, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1669714242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Han, MD has received a total of $2,690 in payments from pharmaceutical and medical device companies, with $1,359 received in 2024. These payments were reported across 105 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,690).
As a Medicare-enrolled provider, Han has provided services to 1,065 Medicare beneficiaries, totaling 1,713 services with total Medicare billing of $134,493. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Owosso, MI
- Active Since 03/21/2013
- Last Updated 10/16/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669714242
Products in Payments
- MOUNJARO (Drug) $249.43
- FARXIGA (Drug) $242.65
- ELIQUIS (Drug) $180.18
- BREZTRI (Drug) $179.62
- AIRSUPRA (Drug) $156.86
- VRAYLAR (Drug) $139.99
- REXULTI (Drug) $125.79
- Rybelsus (Drug) $92.51
- Repatha (Biological) $88.20
- ENTRESTO (Drug) $75.54
- QUTENZA (Drug) $70.78
- JARDIANCE (Drug) $62.58
- LEQVIO (Drug) $60.12
- TRELEGY ELLIPTA (Drug) $55.15
- Otezla (Drug) $52.07
- Ozempic (Drug) $49.72
- EVENITY (Biological) $48.37
- Korlym (Drug) $47.73
- Cologuard Collection Kit (Device) $42.64
- GVOKE HYPOPEN (Drug) $39.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Owosso
Wael Salman, Md, MD
Internal Medicine — Payments: $7,679
Reem Salman, Md, MD
Internal Medicine — Payments: $6,388
Mr. Azmy Allam, Md, MD
Internal Medicine — Payments: $5,810
Mustafa Huseini, Md, MD
Internal Medicine — Payments: $5,023
Mrs. Margaret Purdy, Md, MD
Internal Medicine — Payments: $2,539
Anas Alsara, Md, MD
Internal Medicine — Payments: $2,504